Creotech Quantum

Creotech Quantum S.A. Partners with Milton Essex S.A. to Develop Quantum-Encrypted Biometric Border Control System

On May 15, 2026, Milton Essex S.A. announced the signing of a cooperation and confidentiality agreement with Creotech Quantum S.A. to jointly develop a hardware and software platform for the commercialization of the FaceCOV ActiveSCAN Smart_Border_4.0 QUANTUM system. This innovative solution is designed for field border control and critical infrastructure security, leveraging Creotech Quantum's advanced quantum encryption technology, specifically its Quantum Key Distribution (QKD) system.

The agreement outlines mutual interest in commercializing Creotech Quantum's hardware encryption tools and integrating them with Milton Essex's biometric gateway technology. Additionally, the collaboration includes the possibility of jointly applying for grants and research and development programs. Intellectual property rights for solutions developed under the partnership will be determined in separate agreements.

This strategic partnership highlights Creotech Quantum S.A.'s commitment to expanding its quantum technology applications into critical security sectors, aligning with its expertise in secure quantum communication and foundational quantum infrastructure development.

Creotech Quantum S.A. Announces Ordinary General Meeting to Address Financial Reports and Governance Matters

Creotech Quantum S.A., a leading Polish innovator in quantum technologies, has scheduled its Ordinary General Meeting (OGM) for June 12, 2026, at its headquarters in Warsaw. The agenda includes the presentation and approval of the company's financial report for the fiscal year ending December 31, 2025, which revealed a net loss of PLN 70,327.59. The loss is attributed to initial operational costs during the company's establishment phase. The meeting will also address governance matters, including the approval of the management and supervisory board's activities, the decision to cover the loss with future profits, and the evaluation of the remuneration report for board members. Additionally, the company will discuss granting discharge to board members for their duties performed in 2025.

The meeting will provide shareholders with an opportunity to review the company's financial performance and governance practices, ensuring transparency and accountability. The full documentation and agenda are available on the company's official website.

Relevance to Creotech Quantum S.A.: This announcement highlights Creotech Quantum's commitment to maintaining transparency and addressing financial and governance matters, aligning with its profile as a key player in the quantum economy and critical infrastructure sector.

Creotech Quantum S.A. Launches Series D Share Offering to Accelerate Strategic Growth

Creotech Quantum S.A., a leading Polish innovator in quantum technologies and advanced engineering solutions, has announced the launch of a public offering of up to 350,000 Series D ordinary shares. The company’s management board has approved a capital increase within the authorized capital framework, excluding pre-emptive rights for existing shareholders. The offering will be conducted through a private subscription, with Dom Maklerski Banku Ochrony Środowiska S.A. acting as the offering coordinator and CC Group sp. z o.o. serving as the financial and investor relations advisor.

The company aims to raise approximately PLN 75 million, an increase from the initially planned amount, to fund its strategic initiatives. These include advancing research and development efforts, accelerating the market introduction of new products, and enhancing financial liquidity to participate in large-scale tenders and potential acquisitions. The accelerated book-building process for the offering will target qualified investors, select individuals, and entities meeting specific investment thresholds. The process is set to conclude on May 13, 2026, with the final issue price and allocation to be determined thereafter.

Creotech Quantum S.A. has also granted priority rights to shareholders holding at least 0.5% of the company’s shares as of May 11, 2026, provided they meet specific documentation requirements during the book-building process. The offering will not require the publication of a prospectus, as it falls under exemptions outlined in EU regulations.

Relevance to Creotech Quantum S.A.: This development aligns with Creotech Quantum S.A.'s mission to expand its role in the global quantum economy by securing additional funding to enhance its R&D capabilities, introduce cutting-edge products, and compete in large-scale tenders, reinforcing its position as a leader in quantum technology solutions.

Creotech Quantum S.A. Plans Capital Raise to Accelerate R&D and Market Expansion

Warsaw-based Creotech Quantum S.A., a leader in quantum technology solutions, has announced plans to raise approximately PLN 55-60 million in capital over the next two years to support its ambitious growth strategy. The company is considering a share issuance by mid-2026 to secure the necessary funding. Additionally, Creotech Quantum intends to continue leveraging national and international grant programs, including projects commissioned by the European Commission and the European Space Agency, to co-finance its research and development (R&D) efforts.

The company plans to allocate 50%-65% of the raised funds to R&D and organizational expansion. Key initiatives include:

• Development of next-generation Quantum Key Distribution (QKD) systems for terrestrial infrastructures.
• Creation of single-photon detectors and QKD receivers for optical ground stations (OGS) to enable secure quantum communication from orbit.
• Advancement of new-generation cameras for space safety systems.
• Development of next-generation electronics for quantum processor control.
• Enhancement of operational structures, including ISO/NIS2 compliance, security infrastructure, and engineering capabilities.

The remaining funds will focus on business development and commercialization, including:

• Market introduction of the company's first QKD system and other QKD-related products.
• Production of advanced astronomical and quantum cameras for demonstrations and pilot testing.
• Expansion of the business division, including sales and marketing teams, and participation in international trade fairs and conferences.
• Stocking proprietary products to ensure quick order fulfillment and cost optimization through larger production batches.

Creotech Quantum also hinted at the possibility of achieving its strategic goals through acquisitions or partial acquisitions.

Relevance: This announcement aligns with Creotech Quantum S.A.'s mission to advance foundational technologies for the quantum economy, including secure quantum communication and cutting-edge quantum infrastructure solutions.

Creotech Quantum S.A. Announces 2026 Financial Reporting Schedule

Creotech Quantum S.A., headquartered in Warsaw, has officially disclosed the schedule for its periodic financial reports for 2026. The company plans to release its annual report for 2025 on April 28, 2026, followed by the semi-annual report for the first half of 2026 on September 30, 2026. Additionally, quarterly reports are set for publication on June 1, 2026 (Q1 2026) and November 30, 2026 (Q3 2026). Any changes to these dates will be communicated through current reports, as per regulatory requirements.

The announcement aligns with Creotech Quantum S.A.'s commitment to transparency and compliance with financial reporting standards, ensuring stakeholders remain informed about the company's performance and strategic direction.

Relevance: This announcement underscores Creotech Quantum S.A.'s dedication to maintaining regulatory compliance and fostering trust among investors, which is crucial for its growth in the competitive quantum technology sector.

Allianz Polska Becomes Shareholder in Creotech Quantum S.A. Following Corporate Restructuring

Warsaw-based Creotech Quantum S.A. announced today that Allianz Polska Open Pension Fund (Allianz OFE), managed by Powszechne Towarzystwo Emerytalne Allianz Polska S.A., has acquired a 5.41% stake in the company. This development follows the allocation of 235,684 shares to Allianz OFE as part of a corporate restructuring, which involved the spin-off of Creotech Quantum S.A. from its parent company, Creotech Instruments S.A., on a 1:1 basis. The transaction was finalized on April 16, 2026, and officially reported on April 17, 2026.

Creotech Quantum S.A. specializes in cutting-edge engineering solutions for the quantum economy, including quantum processor control systems, secure quantum communication technologies, and advanced measurement instruments. The acquisition by Allianz Polska highlights growing investor confidence in the company’s innovative contributions to the quantum technology sector.

Relevance: This development underscores Creotech Quantum S.A.'s strategic importance in the quantum economy and its ability to attract institutional investors, further solidifying its position as a key player in the industry.